Duphafral Multivitamin 9 Solution for Injection

Nazione: Regno Unito

Lingua: inglese

Fonte: VMD (Veterinary Medicines Directorate)

Principio attivo:

Alpha Tocopheryl Acetate, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Nicotinamide, Pyridoxine Hydrochloride, Retinol Palmitate, Riboflavine Sodium Phosphate, Thiamine Hydrochloride

Commercializzato da:

Zoetis UK Limited

Codice ATC:

QA11BA

INN (Nome Internazionale):

Alpha Tocopheryl Acetate, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Nicotinamide, Pyridoxine Hydrochloride, Retinol Palmitate, Riboflavine Sodium Phosphate, Thiamine Hydrochloride

Forma farmaceutica:

Solution for injection

Tipo di ricetta:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Gruppo terapeutico:

Horses

Area terapeutica:

Vitamin

Stato dell'autorizzazione:

Expired

Data dell'autorizzazione:

1998-01-08

Scheda tecnica

Revised: February 2014
AN: 01466/2013
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Duphafral Multivitamin 9 Solution for injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCES:
per ml
Retinol palmitate (Vitamin A)
15,000 IU
Cholecalciferol (Vitamin D
3
)
25 mcg
Alpha tocopheryl acetate (Vitamin E)
20 mg
Thiamine Hydrochloride (Vitamin B
1
)
10 mg
Riboflavin Sodium Phosphate (Vitamin B
2
)
5 mg
Pyridoxine Hydrochloride (Vitamin B
6
)
3 mg
Nicotinamide
35 mg
Dexpanthenol
25 mg
Cyanocobalamin (Vitamin B
12
)
25 mcg
EXCIPIENT(S):
Chlorocresol (as preservative)
1 mg
Butylhydroxyanisole (E320)
0.1 mg
Butylhydroxytoluene (E321)
0.1 mg
Disodium Edetate
0.5 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection
A clear orange liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention and treatment of vitamin deficiencies in horses,
particularly
during periods of illness, convalescence and general unthriftiness.
4.3
CONTRAINDICATIONS
None
Revised: February 2014
AN: 01466/2013
Page 2 of 4
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
None.
ii)
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Care should be taken to avoid accidental self-injection. Wash hands
after use.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Duphafral Multivitamin 9 can be safely administered to pregnant or
lactating
horses.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by intramuscular or subcutaneous injection.
Horses:
20-30ml
The injection may be repeated at intervals of 10-14 days. Normal
aseptic
precautions should be observed.
4.10
OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF